DeuterOncology

About:

DeuterOncology is a preclinical-stage biotech company.

Website: https://www.deuteroncology.com

Top Investors: Meusinvest (Noshaq), Newton Biocapital, Investsud

Description:

DeuterOncology is a preclinical-stage biotech company focusing on the development of a first-in-class dual MET and RAS pathway inhibitor for targeted cancer therapies.

Total Funding Amount:

5.65M EUR

Headquarters Location:

Geel, Antwerpen, Belgium

Founded Date:

2020-01-01

Founders:

Timothy Perera

Number of Employees:

11-50

Last Funding Date:

2023-01-19

IPO Status:

Private

Industries: